BFRG Bullfrog AI Holdings, Inc.

$BFRG Earnings scheduled to be, before the bell tomorrow, Nov 13th. The chart is ready for a move up...so I like the setup!

$BFRG Following are insights from Microsoft Copilot. The most meaningful statement in the entire presentation was not the technology discussion. It was the repeated assertion that the pharma partner wants to expand the relationship and that BullFrog may be able to move from pilot-style engagements to larger standard pharma contracts. For BFRG shareholders, the next 6-12 months likely hinge on three developments: 1. Identification or eventual disclosure of the Top-5 pharma partner. 2. Expansion of that relationship into additional programs. 3. Conversion of the stated 36-opportunity pipeline into signed contracts. If those occur, the story changes from "interesting AI technology" to "commercial adoption by global pharma," which is where valuations in this sector typically begin to re-rate. Overall, I would characterize this presentation as commercially encouraging and execution-focused, with the strongest signal being management's confidence around follow-on pharma business.

$BFRG quietly creeping up back to where management bought their shares with personal money

$BFRG Anytime this company wants to release some real news, and not just "we're presenting at this dog and pony show" that'll be great.

$BFRG on the last conference Vin just attended he sounded the absolute most confident than he ever has. Just one decent deal here will make this company profitable and compliant. They have built a nice company here just strike a real deal here now! Sounds like at least one or 2 deals are possible in Q4 according to CEO. Could make an announcement soon enough. Slowing adding to this rock bottom price. Don’t forget management just bought around these levels

$BFRG director of PR job filled along with other data scientist role, now HR job posted, good sign they’re filling positions and ramping up, they must see a lot more work in the near term

$BFRG Key quotes: - We're not looking to develop drugs. We're all about revenue. I think optimistic about this fourth quarter. I think we're going to have multiple opportunities. And we're going to continue growing from there. So really excited about the direction we're headed. The other thing is, we want to take our tech stack and make it an enterprise solution. - So the first one took one year. From the first conversation to closing the deal. And I think that's sort of the generally accepted sales cycle. Nine to 18 months for Big Pharma. We already have others in our pipeline. I think there's an opportunity to actually close one or two of those this quarter. - The deals that we're really going after, we'll call them bio bucks deals. So if you ever read about the billion-dollar multi-billion-dollar deal with an AI and a Big Pharma, those are called bio bucks. That means maybe there's 50 million upfront. There's milestone payments. There's royalties. So you have cash flow stream . . .

$BFRG FWIW, the following is a summary of the presentation generated by Microsoft Copilot (AI/SI):

$BFRG Price Target $3.00 Q1 ignore tax loss sell/rebuys. 10 targets in MDD study... have to believe at least 2 will hit.

$BFRG Gann: any moves over 60 after 11/21 carry the potential for more advances into JPM.

$BFRG Gann update 2) there is a significant PTM date match also near June 12th. The ruling planet of that area is Gemini. Gemini and Mercury rules information. Mercury retrograde ends today.